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A total of 21 of 22 independent isolates of cystic fibrosis-associated Pseudomonas aeruginosa were found
to be lysogenic for DNA-containing, complex capsid viruses. Several of the phages demonstrated the ability
to select mucoid cells from populations of nonmucoid bacteria. Conversion to mucoid growth was more
frequently achieved when phages were isolated from mucoid as opposed to nonmucoid cystic fibrosis-
associated strains.
In progressive Pseudomonas aeruginosa infections of the
lungs of cystic fibrosis (CF) patients, strains which produce
copious amounts of alginate (mucoid variants) are isolated
from more than 90% of affected individuals (2, 3). Infection
by temperate bacteriophages has been proposed as a mecha-
nism for the conversion of P. aeruginosa from the nonmu-
coid to the mucoid phenotype (4, 13, 20). P. aeruginosa
bacteriophages are present in the sputa of patients with
chronic P. aeruginosa bronchopulmonary infections (19)
and, therefore, potentially influence the P. aeruginosa popu-
lation at these sites of infection. Martin (14) observed that
mucoid clones could be subcultured from the bacterial lawn
surrounding areas of phage lysis. Zierdt and Schmidt (21)
correlated dissociation of mucoid isolates from CF patients
with changes in their phage-typing characteristics and sug-
gested that the mucoid phenotype was the result of a phage-
mediated conversion. Govan (6) has reported "conversion"
of nonmucoid strains by selection for survivors of phage E79
infection. We examined the lysogenic state of strains of P.
aeruginosa isolated from the sputa of CF patients to deter-
mine whether viruses potentially capable of inducing phage
conversion are present in these isolates.
Twenty-two strains of CF-associated P. aeruginosa (Table
1) were tested for the presence of temperate bacteriophages.
Overnight cultures of each CF-associated isolate were grown
in Luria broth medium (15) and centrifuged (5,000 to 7,000
rpm for 10 min) to remove bacterial cells and cellular debris.
The supernatant fluid was then filtered through a membrane
filter (0.45 ,Lm mean pore size; Millipore Corp.) and tested
for the presence of PFUs by using strain PAO1 (17), strain
PAT2 (20), and each of the other CF isolates as hosts. Of the
22 strains tested, only RM1414 did not release phage detect-
able as plaques on at least one of the tester strains (Table 1).
Titers ranging from 106 to 109 PFU/ml were obtained. All
plaques were of a typical turbid morphology indicative of
temperate bacteriophages. A total of 8 strains produced
higher titers of phage when grown at 37°C; the other 11
strains produced higher titers of spontaneously induced
phage when grown at 30°C (Table 1). Although cleared
lysates of RM1414 did not produce plaques, they did have
the ability to kill almost all of the strains when cross-
streaked against the various strains. RM1414 may contain a
narrow host range or defective phage or a strain-specific
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pyocin. Since studies have shown that most P. aeruginosa
isolates are lysogenic and often multilysogenic (8), it is likely
that our indicator set was too short to identify a strain which
was permissive for plaque formation by phage from this
strain.
Several criteria were chosen to characterize the phages
isolated from these CF isolates. First, radioactively labeled
([3H]adenine) nucleic acid samples isolated from purified
virions of the various phages by the method of Miller et al.
(16) were tested for sensitivity to DNase 1 (12) and RNase A
(13). In all cases, the nucleic acid was found to be sensitive
to DNase I and insensitive to RNase A. Thus, it can be
concluded that the genomes of these phages are composed of
DNA. Second, electron microscopic examination (16) re-
vealed complex capsids with elongated heads and flexible
tails. Some variation in the dimensions of the heads and tails
was noted in phages isolated from different CF-associated
bacterial strains, but no striking differences in capsid mor-
phology were observed. Third, sensitivity to inactivation of
the virion by 5% ether or 5% chloroform was tested. The
majority of the phage isolates were resistant to both chemi-
cals, but isolates sensitive (i.e., reduction in titer of >99% in
4 days) to ether (41404), chloroform (41409 and 41417), or
both (41402) were also detected. Fourth, bacteriophages
from the various CF isolates were examined to determine
whether they were members of any of the recognized
serogroups of P. aeruginosa phages (7, 9, 11). Neutralizing
antisera were prepared against representative phages of each
serological group which contains temperate phages (9).
These included phages B3, D3, F116, and G101 (7, 9, 11, 18).
These antisera were used in neutralization tests against each
of the phages isolated from CF-associated P. aeruginosa
strains (9). No cross-neutralization was found with any of
the CF phages, except that 41417 was neutralized by anti-
phage G101 serum. Therefore, it would appear that the
majority of these phages are not members of a recognized
serogroup of P. aeruginosa temperate viruses.
The data from this study indicate that CF-associated
isolates of P. aeruginosa are usually, if not always, lysogenic
for one or more temperate phages. The phages found in CF
sputa by Tejedor et al. (19) may have their source in the
spontaneous induction of lysogenic bacteria found in the
bronchopulmonary tract of these patients.
Martin (14) and Govan (6) have reported that certain
bacteriophages are capable of converting nonmucoid strains
to the mucoid phenotype. In their studies, neither the phages
nor the bacteria were isolated from CF-associated P. aeru-
717
J. CLIN. MICROBIOL.
TABLE 1. Plaquing capability of bacteriophage isolated from CF-
associated isolates
Plaquing characteristics
Straina Optimum
tempb Host strainsc
(OC)
Mucoid strains'
RM1399
RM1400
RM1402
RM1404
RM1406
RM1407
RM1412
RM1414e
RM1415
RM1417
RM1418
RM1420
Nonmucoid strainsd
RM1401
RM1403
RM1405
RM1408
RM1409
30 PAO1, PAT2, RM1404, RM1406
30 RM1404, RM1406, RM1417,
RM1418
30 PAO1, PAT2, RM1404, RM1405,
RM1410
30 RM1399, RM1400, RM1406,
RM1407, RM1409, RM1410,
RM1411, RM1414, RM1418
37 PAO1, PAT2, RM1404, RM1405,
RM1407, RM1411
37 PAO1, PAT2, RM1402, RM1406,
RM1408
37 PAO1, PAT2
30 PAO1, RM1404, RM1406,
RM1407, RM1410, RM1411,
RM1412
30 PAT2, RM1399, RM1404,
RM1407, RM1412, RM1418
37 PAO1, RM1406
30 PAO1, PAT2
30 RM1400, RM1404, RM1410
30 PAO1, PAT2, RM1401, RM1409,
RM1410, RM1411
37 PAO1, PAT2, RM1401, RM1403,
RM1404, RM1406, RM1407,
RM1408, RM1410, RM1411,
RM1413
30 RM1404, RM1406, RM1407,
RM1411, RM1413
30 RM1401, RM1404, RM1407,
RM1408, RM1410, RM1411,
RM1412, RM1413
RM1410 30 RM1404, RM1408
RM1411 37 PAO1, PAT2, RM1406, RM1410
RM1413 37 PAO1, PAT2, RM1404, RM1411
RM1416 30 PAO1, PAT2, RM1404, RM1406,
RM1407, RM1412, RM1415
RM1419 37 PAO1
Strains RM1399 through RM1403 were from W. Dow, Vander-
bilt University; RM1404 through RM1413 were from C. H. Zierdt,
National Institutes of Health; RM1414 through RM1419 were from
A. von Graevenitz, Yale University; and RM1420 was from the
Centers for Disease Control, Atlanta.
b Optimal titers of spontaneously induced phage were produced
when cultures were grown at this temperature. Plating efficiencies
on the various indicator strains were also maximal at this tempera-
ture.
c Cleared lysates of the strain produced plaques on these strains.
d Colony morphology when grown on Luria agar (15).
Cleared lysates of RM1414 failed to produce plaques on any of
the strains tested. These lysates were able to induce killing of all
strains except RM1404 and RM1414.
ginosa infections of the lung. We wished to test the bacterio-
phages which we had identified for their ability to convert
bacteria to the mucoid phenotype. Cross streaks of nonmu-
coid bacteria (either laboratory strains or strains isolated
from CF infections) were made against bacteriophages (109
PFU/ml) isolated from CF-associated strains. After 24 h of
incubation, the plates were observed for changes in colony
morphology at the bacteria-phage intersection. When mu-
coid colonies were observed, they were picked, and the
mucoid phenotype of the isolated colonies was confirmed by
subcloning.
Phage-mediated conversion could be demonstrated with 6
of the 22 phage lysates (Table 2). Two of these phages were
from nonmucoid CF strains. One of the six strains which
gave rise to converting lysates (RM1414) was the only strain
from which we were unable to obtain PFUs. The converting
factor found in this strain was removed by filtration of cell-
free lysates through a Millipore filter with a mean pore size
of 0.22 ,um. Filtration of cell-free lysates from this strain
through 0.45-,um filters did not remove the factor. Of the 10
CF-associated nonmucoid strains studied, only RM1410 and
RM1411 could be converted to mucoid growth by these
bacteriophages. These phages were also unable to convert
the laboratory strains PAO and PAT. Conversion of strain
PAO to mucoid growth was achieved with two well-charac-
terized phages, F116 and E79. Conversion of non-PAO
strains by E79, a virulent bacteriophage (7), has been
reported by Govan (6).
Phage mediation of induction of alginate synthesis is
consistent with these results. This induction could be due to
one of two mechanisms. The mucoid phenotype could be a
result of lysogenic conversion in which the introduction of
phage-encoded genes into the cell is responsible for the
alteration in the phenotype of the host (9). This hypothesis is
supported by the fact that the vast majority of conversions
were achieved by phages isolated from mucoid as opposed to
nonmucoid strains of P. aeruginosa. Equally plausible is that
the phages may act as selective agents for a subpopulation of
mucoid cells. Here, one might postulate that the mucoid
layer acts to inhibit phage infection, thereby increasing the
survival chance of the mucoid cell over that of the nonmu-
coid cell. This phenomenon is known to occur with Esche-
richia coli and phage lambda (5). This hypothesis is support-
ed by several observations from this and former studies.
Conversion by phages isolated from nonmucoid strains,
although less frequent, was observed. We have found, as did
Govan (6), that conversion can be accomplished by the
virulent phage E79 which cannot establish lysogeny in PAO
hosts. The induction of the mucoid phenotype by antibiotics
(6) and pyocins (10) has been reported. Martin (14) failed to
identify lysogens among the phage-induced, mucoid variants
which she isolated in her study. In addition, Fyfe and Govan
(4) and Banerjee et al. (1) have identified chromosomal loci
involved in the biosynthesis and control of alginate produc-
tion. the accumulation of data requires that the hypothesis
TABLE 2. Phage-mediated conversion of nonmucoid strains to
the mucoid phenotype
Strain convertedb
Phage"
RM1410 RM1411
41403 + +
41404 + +
41406 +
41409 +
41414 + +
41415 + +
aCleared lysates of these strains were able to convert the
nonmucoid strains listed to mucoid growth.
b +, Conversion to mucoid growth; -, no change in colony
morphology.
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that CF strain bacteriophages give mucoid forms a selective
advantage must be considered as a viable mechanism for
mucoid conversion in P. aeruginosa.
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